Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JENNIFER BROOKE VALERIN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1376770255
CMS profile
430951
Location
ORANGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$104,357.53

80 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $74,815.70 49
Incyte Corporation $29,172.75 25
Exelixis Inc. $175.00 1
GlaxoSmithKline, LLC. $67.00 1
Takeda Pharmaceuticals U.S.A., Inc. $47.08 1
Amgen Inc. $37.05 1
JAZZ PHARMACEUTICALS INC. $23.77 1
E.R. Squibb & Sons, L.L.C. $19.18 1

Page 1 of 2; records 1–50 of 80 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JENNIFER BROOKE VALERIN

NPI 1376770255 · CMS profile ID 430951

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

ORANGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 80 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1376770255?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JENNIFER BROOKE VALERIN, NPI 1376770255, CMS profile ID 430951. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 80 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1376770255?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JENNIFER BROOKE VALERIN, NPI 1376770255, CMS profile ID 430951. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 80 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1376770255?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JENNIFER BROOKE VALERIN, NPI 1376770255, CMS profile ID 430951, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 80 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1376770255?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

80 matching records · $104,357.53 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 80 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 80.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $2,740.0012/19/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226022862 CMS
Incyte Corporation $4,110.0012/19/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226022986 CMS
Incyte Corporation $124.5412/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226022797 CMS
Incyte Corporation $1,202.1912/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226023140 CMS
Incyte Corporation $139.2912/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226022817 CMS
Incyte Corporation $801.4512/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226022962 CMS
Incyte Corporation $2,055.0012/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226022874 CMS
Incyte Corporation $4,110.0011/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1225971581 CMS
Incyte Corporation $120.4811/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225971579 CMS
Incyte Corporation $858.7111/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1225971589 CMS
AstraZeneca Pharmaceuticals LP $46.0010/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206416673 CMS
AstraZeneca Pharmaceuticals LP $41.4010/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206488356 CMS
AstraZeneca Pharmaceuticals LP $37.5710/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206508309 CMS
AstraZeneca Pharmaceuticals LP $30.8410/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206717757 CMS
AstraZeneca Pharmaceuticals LP $22.4010/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206956521 CMS
Incyte Corporation $685.0010/15/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1226044292 CMS
AstraZeneca Pharmaceuticals LP $6,560.0010/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1207269416 CMS
Incyte Corporation $745.4010/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1225961591 CMS
Incyte Corporation $2,740.0010/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226032435 CMS
AstraZeneca Pharmaceuticals LP $352.2609/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206194809 CMS
AstraZeneca Pharmaceuticals LP $387.0609/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206442653 CMS
AstraZeneca Pharmaceuticals LP $123.9209/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207286680 CMS
Incyte Corporation $124.9909/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226031819 CMS
Incyte Corporation $33.6009/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226032421 CMS
Takeda Pharmaceuticals U.S.A., Inc. $47.0808/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223939430 CMS
AstraZeneca Pharmaceuticals LP $60.0008/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206230460 CMS
AstraZeneca Pharmaceuticals LP $9.0308/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206789465 CMS
AstraZeneca Pharmaceuticals LP $22.4008/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206844841 CMS
AstraZeneca Pharmaceuticals LP $26.5208/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207039746 CMS
AstraZeneca Pharmaceuticals LP $450.4608/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1207056636 CMS
AstraZeneca Pharmaceuticals LP $6,560.0008/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1206780429 CMS
AstraZeneca Pharmaceuticals LP $5,740.0008/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1206843512 CMS
Incyte Corporation $5,480.0008/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226168643 CMS
AstraZeneca Pharmaceuticals LP $27.8408/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206358994 CMS
AstraZeneca Pharmaceuticals LP $122.1408/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206579304 CMS
AstraZeneca Pharmaceuticals LP $201.7408/05/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206708549 CMS
AstraZeneca Pharmaceuticals LP $575.9708/05/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1207027195 CMS
Incyte Corporation $123.1107/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226168639 CMS
Incyte Corporation $22.4007/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226168641 CMS
Incyte Corporation $629.7207/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226168647 CMS
Incyte Corporation $127.2407/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226169139 CMS
Incyte Corporation $430.9707/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226169175 CMS
Incyte Corporation $30.0007/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226169229 CMS
Incyte Corporation $26.1607/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226170213 CMS
AstraZeneca Pharmaceuticals LP $187.6107/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206167690 CMS
AstraZeneca Pharmaceuticals LP $47.7907/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206634824 CMS
AstraZeneca Pharmaceuticals LP $431.2207/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1207125050 CMS
AstraZeneca Pharmaceuticals LP $6,560.0007/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1206712039 CMS
AstraZeneca Pharmaceuticals LP $6,560.0007/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1207286902 CMS
Incyte Corporation $1,370.0007/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226168595 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $509.00 1
PY2021 $305.24 3
PY2022 $735.99 2
PY2023 $35,493.55 28
PY2024 $46,559.16 37
PY2025 $104,357.53 80

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $129,323.00 25
PY2024 Principal investigator $153,404.74 78
PY2023 Principal investigator $26,830.78 1
PY2022 Principal investigator $20,113.21 1
PY2020 Principal investigator $37,266.60 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $99,360.00 05/05/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1,1b First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF9001 as a Monotherapy and in Combination Therapies in Patients With Advanced Unresectable, Recurrent, or Metastatic Solid Tumors, and Expansion in Selected Indications No dispute reported 06/30/2026 1232936216
Principal investigator 1 Incyte Corporation $590.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485264
Principal investigator 1 Incyte Corporation $186.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485272
Principal investigator 1 Incyte Corporation $990.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485278
Principal investigator 1 Incyte Corporation $632.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485283
Principal investigator 1 Incyte Corporation $6,191.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485288
Principal investigator 1 Incyte Corporation $303.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485295
Principal investigator 1 Incyte Corporation $451.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485302
Principal investigator 1 Incyte Corporation $87.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485307
Principal investigator 1 Incyte Corporation $2,640.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485313
Principal investigator 1 Incyte Corporation $720.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485317
Principal investigator 1 Incyte Corporation $606.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485323
Principal investigator 1 Incyte Corporation $228.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485330
Principal investigator 1 Incyte Corporation $1,511.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485337
Principal investigator 1 Incyte Corporation $252.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485342
Principal investigator 1 Incyte Corporation $259.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485349
Principal investigator 1 Incyte Corporation $742.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485355
Principal investigator 1 Incyte Corporation $1,200.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485361
Principal investigator 1 Incyte Corporation $1,899.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485367
Principal investigator 1 Incyte Corporation $5,500.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485373
Principal investigator 1 Incyte Corporation $3,800.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485379
Principal investigator 1 Incyte Corporation $394.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485387
Principal investigator 1 Incyte Corporation $49.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485393
Principal investigator 1 Incyte Corporation $660.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485399
Principal investigator 1 Incyte Corporation $73.00 02/24/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors No dispute reported 06/30/2026 1240485405